David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 28.91% |
| 2 | Technology | 15.8% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Healthcare | 10.16% |
| 5 | Financials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Planet Fitness
PLNT
$3.91B
| $2.9M | ﹤0.01% |
38,900
| – | – |
|
|
JOYY
2127
CALL
JOYY Inc
JOYY
$3.66B
| $2.9M | ﹤0.01% |
54,900
| – | – |
|
2128
Sasol
SSL
$7.44B
| $2.9M | ﹤0.01% |
134,003
+9,947
| +8% | +$190K |
|
2129
PUT
Corteva
CTVA
$55B
| $2.89M | ﹤0.01% |
97,878
| – | – |
|
2130
Prologis
PLD
$135B
| $2.89M | ﹤0.01% |
32,443
-20,168
| -38% | -$1.79M |
|
2131
Cytokinetics
CYTK
$10.8B
| $2.89M | ﹤0.01% |
272,550
+232,113
| +574% | +$2.38M |
|
2132
CALL
Air Products & Chemicals
APD
$68B
| $2.89M | ﹤0.01% |
12,300
-6,400
| -34% | -$1.44M |
|
2133
Entravision Communication
EVC
$747M
| $2.88M | ﹤0.01% |
1,099,787
+65,535
| +6% | +$179K |
|
2134
PUT
W.P. Carey
WPC
$16B
| $2.88M | ﹤0.01% |
36,756
+10,210
| +38% | +$855K |
|
2135
First Bancorp
FBNC
$2.63B
| $2.87M | ﹤0.01% |
72,028
-1,494
| -2% | -$57.2K |
|
2136
PUT
EPAM Systems
EPAM
$5.82B
| $2.86M | ﹤0.01% |
13,500
-1,000
| -7% | -$197K |
|
|
AYX
2137
CALL
DELISTED
Alteryx Inc
AYX
| $2.86M | ﹤0.01% |
28,600
-20,000
| -41% | -$2.03M |
|
|
ESPR
2138
DELISTED
Esperion Therapeutics
ESPR
| $2.86M | ﹤0.01% |
47,975
+17,885
| +59% | +$804K |
|
|
THCBU
2139
DELISTED
Tuscan Holdings Corp. Unit
THCBU
| $2.86M | ﹤0.01% |
272,120
| – | – |
|
|
K
2140
PUT
DELISTED
Kellanova
K
| $2.85M | ﹤0.01% |
43,878
| – | – |
|
2141
Church & Dwight Co
CHD
$24.3B
| $2.85M | ﹤0.01% |
40,463
-1,547
| -4% | -$110K |
|
|
CAI
2142
DELISTED
CAI International, Inc.
CAI
| $2.84M | ﹤0.01% |
98,120
-15,262
| -13% | -$370K |
|
2143
PUT
Papa John's
PZZA
$765M
| $2.83M | ﹤0.01% |
44,800
| – | – |
|
2144
Center Bancorp
CNOB
$1.61B
| $2.83M | ﹤0.01% |
109,874
-1,138
| -1% | -$27.7K |
|
2145
PUT
IPG Photonics
IPGP
$3.29B
| $2.83M | ﹤0.01% |
19,500
-29,200
| -60% | -$4.06M |
|
|
AKCA
2146
DELISTED
Akcea Therapeutics Inc
AKCA
| $2.83M | ﹤0.01% |
166,789
+109,992
| +194% | +$2.05M |
|
2147
PUT
Fluor
FLR
$7.24B
| $2.82M | ﹤0.01% |
149,500
+29,200
| +24% | +$531K |
|
|
REVG
2148
DELISTED
REV Group
REVG
| $2.82M | ﹤0.01% |
230,635
+192,949
| +512% | +$2.44M |
|
2149
Fresenius Medical Care
FMS
$12.4B
| $2.81M | ﹤0.01% |
76,405
+68,731
| +896% | +$2.44M |
|
2150
CALL
Acuity Brands
AYI
$10.2B
| $2.8M | ﹤0.01% |
20,300
-21,100
| -51% | -$2.71M |
|
Similar funds
David Shaw's Q4 2019 Portfolio in Review
As of Q4 2019, David Shaw held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
David Shaw withdrew a net $3.91B in Q4 2019, closing 412 positions and reducing 1,498 holdings. Its most notable exit was Celgene Corp, an estimated $460M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Tesla worth $501M.
- David Shaw's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- David Shaw added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- David Shaw's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- David Shaw fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- David Shaw's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- David Shaw opened 572 new positions and closed 412 in Q4 2019.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.